Others

Fortis Healthcare Ltd. - Disclosure(S) Under Regulation 30 - Sale Or Disposal Of MSCL

| Updated on July 08, 2019 Published on July 08, 2019

Dear Sir(s),

This is in continuation of our intimation ref. FHL/SEC/2019-20 dated May 17, 2019 captioned sale or disposal of MSCL and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Fortis Healthcare International Limited (FHIL), a wholly owned subsidiary of Fortis Healthcare Limited (FHL or the Company), which is incorporated in Mauritius, has consummated the Proposed Transaction of sale of the entire shareholding held by FHIL in The Medical and Surgical Centre Limited (MSCL) [renamed as C-Care (Mauritius) Ltd.], representing 28.89% (164,670,801 shares) holding of the total issued and paid up equity share capital of MSCL, with CIEL Limited, CIEL Healthcare Limited (collectively referred to as CIEL). The entire stake of FHIL in MSCL is now divested.

The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith as Annexure A.

This is for your information and records please.

Pdf Link: Fortis Healthcare Ltd. - Disclosure(S) Under Regulation 30 - Sale Or Disposal Of MSCL

Source : BSE - www.bseindia.com

Published on July 08, 2019
This article is closed for comments.
Please Email the Editor